VectorBuilder Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 600

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

VectorBuilder General Information

Description

Provider of gene delivery services intended to accelerate genetic engineering research and therapeutic development. The company offers an online design studio for custom vector construction, viral packaging, library screening, stable cell line generation, and GMP manufacturing, enabling biotechnology and pharmaceutical organizations to transition gene delivery projects from discovery to clinical production.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1010 West 35th Street
  • Suite 515
  • Chicago, IL 60609
  • United States
+1 (800)
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Corporate Office
  • 1010 West 35th Street
  • Suite 515
  • Chicago, IL 60609
  • United States
+1 (800)

VectorBuilder Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VectorBuilder Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator Completed Profitable
7. IPO 13-Jun-2024 Cancelled Profitable
6. Secondary Transaction - Private 01-May-2023 Completed Profitable
5. Secondary Transaction - Private 27-Mar-2023 Completed Profitable
4. Later Stage VC (Series C) 08-Oct-2022 Completed Profitable
3. Later Stage VC 01-Feb-2022 Completed Profitable
2. Later Stage VC (Series A) 26-Sep-2021 $3.87M $3.87M Completed Generating Revenue
1. Accelerator/Incubator 14-Mar-2014 Completed Startup
To view VectorBuilder’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

VectorBuilder Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of gene delivery services intended to accelerate genetic engineering research and therapeutic development. The
Biotechnology
Chicago, IL
600 As of 2022

Suzhou, China
 

New York, NY
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VectorBuilder Competitors (5)

One of VectorBuilder’s 5 competitors is Ubrigene, a Venture Capital-Backed company based in Suzhou, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ubrigene Venture Capital-Backed Suzhou, China
LineaRx, Inc. Corporation New York, NY
Synbio Technologies Venture Capital-Backed Suzhou, China
PackGene Venture Capital-Backed Houston, TX
GenScript Formerly VC-backed Nanjing, China
You’re viewing 5 of 5 competitors. Get the full list »

VectorBuilder Patents

VectorBuilder Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026145253-A1 Nucleic acid molecule and use thereof, and virus particle, and preparation method therefor and use thereof Pending 30-Dec-2024
WO-2026145252-A1 Promoter and use thereof Pending 30-Dec-2024
WO-2026103958-A1 Lipid nanoparticle conjugate, and preparation method therefor and use thereof Pending 12-Nov-2024
WO-2026056784-A1 Photoreceptor cell-specific bidirectional promoter and use thereof Pending 10-Sep-2024
WO-2025261326-A1 Cone-specific promoter and use thereof Pending 20-Jun-2024 C07K14/435
To view VectorBuilder’s complete patent history, request access »

VectorBuilder Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VectorBuilder Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
C&D Emerging Industry Equity Investment Corporate Venture Capital Minority
Guangzhou Yuexiu Industrial Investment Fund Management PE/Buyout Minority
HKJ Group Government Minority
Legend Capital Venture Capital Minority
Tongling State-owned Capital Operation Holding Group Government Minority
You’re viewing 5 of 11 investors. Get the full list »

VectorBuilder FAQs

  • When was VectorBuilder founded?

    VectorBuilder was founded in 2014.

  • Where is VectorBuilder headquartered?

    VectorBuilder is headquartered in Chicago, IL.

  • What is the size of VectorBuilder?

    VectorBuilder has 600 total employees.

  • What industry is VectorBuilder in?

    VectorBuilder’s primary industry is Biotechnology.

  • Is VectorBuilder a private or public company?

    VectorBuilder is a Private company.

  • What is VectorBuilder’s current revenue?

    The current revenue for VectorBuilder is .

  • How much funding has VectorBuilder raised over time?

    VectorBuilder has raised $69.9M.

  • Who are VectorBuilder’s investors?

    C&D Emerging Industry Equity Investment, Guangzhou Yuexiu Industrial Investment Fund Management, HKJ Group, Legend Capital, and Tongling State-owned Capital Operation Holding Group are 5 of 11 investors who have invested in VectorBuilder.

  • Who are VectorBuilder’s competitors?

    Ubrigene, LineaRx, Inc., Synbio Technologies, PackGene, and GenScript are competitors of VectorBuilder.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process